1
|
Moayedi Y, Truby LK, Foroutan F, Han J, Guzman J, Angleitner P, Sabatino M, Felius J, van Zyl JS, Rodenas-Alesina E, Fan CP, DeVore AD, Miller R, Potena L, Zuckermann A, Farrero M, Chih S, Farr M, Hall S, Ross HJ, Khush KK. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation. J Card Fail 2023:S1071-9164(23)00382-2. [PMID: 37907150 DOI: 10.1016/j.cardfail.2023.09.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 09/29/2023] [Accepted: 09/30/2023] [Indexed: 11/02/2023]
Abstract
BACKGROUND Primary Graft Dysfunction (PGD) is the leading cause of morbidity and mortality early after heart transplant (HT). The International Consortium on PGD is a multicenter collaboration dedicated to identifying the clinical risk factors for PGD in the contemporary era of HT. The objectives of the current report were to 1) assess the incidence of severe PGD in an international cohort, 2) evaluate the performance of the most validated PGD risk tool, the RADIAL score, in a contemporary cohort, and 3) redefine clinical risk factors for severe PGD in the current era of HT. METHODS This is a retrospective, observational study of consecutive adult HT recipients between 2010 and 2020 in 10 centers in the United States, Canada, and Europe. Patients with severe PGD were compared to those without severe PGD (comprising those with no, mild and moderate PGD). The RADIAL score was calculated for each transplant recipient. The discriminatory power of the RADIAL score was evaluated using receiver operating characteristic (ROC) analysis and its calibration was assessed by plotting the percentage of PGD predicted versus observed. To identify clinical risk factors associated with severe PGD, we performed multivariable mixed-effects logistic regression modeling to account for among-center variability. RESULTS A total of 2,746 patients have been enrolled in the registry to date, including 2,015 (73.4%) from North America, and 731 (26.6%) from Europe. 215 participants (7.8%) met the criteria for severe PGD. There was an increase in the incidence of severe PGD over the study period (p-value for trend by difference sign test = 0.004). The Kaplan Meier estimate for 1-year survival was 75.7% [95%CI 69.4-80.9%] in patients with severe PGD as compared to 94.4% [95% CI 93.5-95.2%] in those without severe PGD (log-rank p-value <0.001). The RADIAL score performed poorly in our contemporary cohort and was not associated with severe PGD with an AUC of 0.53 (95%CI 0.48-0.58). In the multivariable regression model, acute preoperative dialysis (OR 2.41, 95% CI 1.31 - 4.43), durable LVAD support (OR 1.77, 95% CI 1.13 - 2.77), and total ischemic time (OR 1.20 for each additional hour, 95% CI 1.02 - 1.41) were associated with an increased risk of severe PGD. CONCLUSIONS Our consortium has identified an increasing incidence of PGD in the modern transplant era. We identified contemporary risk factors for this early post-transplant complication, which confers a high mortality risk. These results may enable the identification of patients at high risk for developing severe PGD in order to inform peri-transplant donor and recipient management practices.
Collapse
Affiliation(s)
- Y Moayedi
- Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Canada
| | - L K Truby
- UT Southwestern Medical Center, Dallas, USA
| | - F Foroutan
- Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Canada
| | - J Han
- University of Chicago, Chicago, USA
| | - J Guzman
- Hospital Clinic, Barcelona, Spain
| | | | | | - J Felius
- Baylor Medical Center, Dallas, USA
| | | | - E Rodenas-Alesina
- Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Canada
| | - C-P Fan
- Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Canada
| | - A D DeVore
- Duke University Medical Center, Durham, USA
| | - R Miller
- University of Calgary, Calgary, Canada
| | - L Potena
- University of Bologna, Bologna, Italy
| | | | | | - S Chih
- Ottawa Heart, Ottawa, Canada
| | - M Farr
- UT Southwestern Medical Center, Dallas, USA
| | - S Hall
- Baylor Medical Center, Dallas, USA
| | - H J Ross
- UT Southwestern Medical Center, Dallas, USA
| | | |
Collapse
|
2
|
Tan Y, Murala J, Heid C, Amin A, Farr M, Drazner M, Peltz M. Fontan Failure with Arch Aneurysm and Cirrhosis Managed with Orthotopic Heart Transplantation and Arch Replacement Alone. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Weisberg A, Murala J, Heid C, Amin A, Drazner M, Farr M, Wait M, Jessen M, Huffman L, Hackmann A, Peltz M. Failed Fontan Physiology with Associated Liver Disease in Adults- Are Two Organs Better Than One. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Godfrey S, Araj F, Hendren N, Amin A, Hardin E, Garg S, Grodin J, Morlend R, Thibodeau J, Peltz M, Drazner M, Farr M, Mammen P. Survival of the Unfittest: The Longest Living LVAD-Supported Patient with DMD-Associated Cardiomyopathy. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
5
|
Han J, Moayedi Y, Truby L, Foroutan F, Bofarull JG, Saha S, Angleitner P, Sabatino M, Henricksen E, Luikart H, van Zyl J, Tremblay-Gravel M, Noly P, Segovia-Cubero J, Alesina ER, Potena L, Takeda K, Felius J, Clarke B, DeVore A, Kim G, Miller R, Zuckermann A, Farr M, Crespo-Leiro M, Hall S, Torres MF, Fan C, Ross H, Khush K, Chih S. Incidence and Predictors of Vasoplegia after Heart Transplantation: Results from the International PGD Consortium. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
6
|
Stehlik J, Schroder J, Pinney S, Patel C, D'Alessandro D, Goldstein D, Jorde U, Patel S, Mani D, Esmailian F, Kobashigawa J, Takeda K, Uriel N, Pham S, Patel P, Kai M, Sun B, Shah A, Ono M, Couper G, DeNofrio D, Vest A, Joyce D, DeVore A, Mallidi H, Itoh A, Mehra M, Givertz M, Milano C, Farr M. First Report of the Transmedics Organ Care System Heart Perfusion Registry. A Multi-Institutional Outcomes Analysis. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
7
|
Heid C, Hackmann A, Hendren N, Huffman L, Farr M, Amin A, Drazner M, Grodin J, Yeganeh S, Ring W, Peltz M. Sternal Sparing Left Ventricular Assist Devices in Patients with who Class 2 or Greater Obesity. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
8
|
Milano C, Schroder J, Farr M, DeVore A, D'Alessandro D, Goldstein D, Jorde U, Patel S, Daneshmand M, Pinney S, Esmailian F, Kobashigawa J, Takeda K, Uriel N, Pham S, Patel P, Kai M, Sun B, Shah A, Ono M, Couper G, DeNofrio D, Vest A, Joyce D, Mallidi H, Itoh A, Mehra M, Givertz M, Patel C, Stehlik J. Demographics and Outcomes of Clinical Trial vs Initial Post-Approval Use of Transmedics Organ Care System Heart. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
9
|
Asllanaj B, Farr M, McWhorter Y. Acute partial papillary muscle rupture as a rare complication following non-ST elevation myocardial infarction. SAGE Open Med Case Rep 2023; 11:2050313X221145618. [PMID: 37113388 PMCID: PMC10126593 DOI: 10.1177/2050313x221145618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2022] [Accepted: 11/28/2022] [Indexed: 04/29/2023] Open
Abstract
Papillary muscle rupture is a life-threatening complication of acute myocardial infarction that most commonly occurs 2-7 days after the infarct. We present a rare case of acute partial anterolateral papillary muscle rupture following non-ST elevation myocardial infarction. Our patient was an elderly male who had a detached anterolateral papillary muscle, which required emergent mitral valve replacement. Papillary muscle rupture is a rare complication of acute myocardial infarction, and anterolateral muscle rupture occurs even less commonly. When papillary muscle rupture is diagnosed, patients need to be emergently referred to cardiothoracic surgery as mortality without surgery is over 90% within a week.
Collapse
Affiliation(s)
- Blerina Asllanaj
- Department of Internal Medicine, HCA
Healthcare, MountainView Hospital, Las Vegas, NV, USA
- Blerina Asllanaj, Department of Internal Medicine,
HCA Healthcare, MountainView Hospital, 2880 N Tenaya Way, Las Vegas, NV 89128, USA.
| | - Matthew Farr
- Department of Anesthesiology, HCA Healthcare,
MountainView Hospital, Las Vegas, NV, USA
| | - Yi McWhorter
- Department of Critical Care Medicine, HCA
Healthcare, MountainView Hospital, Las Vegas, NV, USA
| |
Collapse
|
10
|
Mitra D, Farr M, Nagarajan P, Bishop A, Farooqi A, Jazaeri A, Jhingran A, Lin L, Klopp A, Amaria R, McQuade J, Glitza I, Guadagnolo B. Gynecologic Melanoma: A 25-Year Institutional Experience. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
11
|
Guzman Bofarull J, Han J, Moayedi Y, Truby LK, Foroutan F, Miller R, Potena L, Zuckermann A, Chih S, Farr M, Hall S, Ross HJ, Khush K, Farrero M. Predictors of early renal dysfunction after heart transplantation: a report from the International Consortium on Primary Graft Dysfunction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Renal dysfunction is a common complication after heart transplantation (HT). Renal replacement therapy (RRT) after HT has been associated with increased risk of death. Long-term renal dysfunction is associated mainly to immunosuppressive therapy but is also strongly related to post-transplant renal failure. Predictors of early renal dysfunction after HT have not been clearly identified.
Purpose
We aimed to define predictors of early renal dysfunction after HT.
Methods
Our consortium includes 10 centers in the US, Canada and Europe. We collected data on all consecutive single-organ HT recipients from 2010 to 2020. The primary outcome was early renal dysfunction (ERD), defined as a composite of need for RRT or creatinine ≥2.5 mg/dL 24 hours after HT. We assessed the incidence of early renal dysfunction and performed univariate and multivariate analyses to identify the recipient and transplant characteristics associated with its development.
Results
We included 2,764 HT recipients: 282 (10.2%) presented early renal dysfunction and 2482 (89.8%) did not. Recipients who presented postoperative renal dysfunction were more frequently male, Caucasian, with previous sternotomy, higher baseline creatinine, longer ischemic time and worse donor LVEF. They were also more likely to be under RRT, intravenous inotropes or ECMO support and there was more incidence of severe primary graft dysfunction (PGD) (Table 1). Multi-variable logistic regression demonstrated that the strongest predictors for post-transplant renal dysfunction were development of severe PGD (OR 5.26, 2.88–9.62, p<0,001) and RRT prior to HT (OR 5.80, 2.93–11.5, p<0.001). Other predictors were male sex, previous sternotomy, long ischemic time and need for inotropes prior to HT.
Conclusions
Early renal dysfunction is a common complication after HT with an incidence around 10% in a large and contemporary cohort. The presence of PGD and need for RRT pre-transplant were the strongest predictors for its development. Interestingly, emergent transplantation or need for MCS were not independently associated with ERD. Further studies are needed to identify patients at high risk of early and late kidney dysfunction that may benefit from combined transplantation.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - J Han
- Stanford University Medical Center , Stanford , United States of America
| | - Y Moayedi
- University of Toronto , Toronto , Canada
| | - L K Truby
- Duke University Medical Center , Durham , United States of America
| | - F Foroutan
- University of Toronto , Toronto , Canada
| | - R Miller
- University of Calgary , Calgary , Canada
| | - L Potena
- University of Bologna , Bologna , Italy
| | | | - S Chih
- Ottawa Heart Institute , Ottawa , Canada
| | - M Farr
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - S Hall
- Baylor University Medical Center , Dallas , United States of America
| | - H J Ross
- University of Toronto , Toronto , Canada
| | - K Khush
- Stanford University Medical Center , Stanford , United States of America
| | - M Farrero
- Hospital Clinic of Barcelona , Barcelona , Spain
| |
Collapse
|
12
|
Moayedi Y, Foroutan F, Truby L, Han J, Angleitner P, Guzman J, Sabatino M, Felius J, Zafar H, Law D, Van Zyl J, Tremblay-Gravel M, Segovia J, Devore A, Kim G, Lasarte MR, Knezevic I, Noly P, Farr M, Zuckermann A, Potena L, Ferrero M, Miller R, Fan S, Chih S, Hall S, Khush K, Ross H. Using Machine Learning to Develop a Contemporary Primary Graft Dysfunction Prediction Model: The International Consortium on PGD. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
13
|
Pinney S, Farr M, Milano C, Shah A, Stehlik J. Organ Care System Heart Perfusion Registry (OHP Registry) - Overview of a National Data Repository of Ex-Vivo Perfusion in DBD and DCD Heart Transplantation. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
14
|
Truby L, Moayedi Y, Foroutan F, Han J, Guzman J, Farrero M, Zafar H, Felius J, van Zyl J, Hall S, Law D, Chih S, Angleitner P, Sabatino M, DeVore A, Miller R, Potena L, Zuckermann A, Ross H, Khush K, Farr M. Bridge to Transplant with Durable Left Ventricular Assist Device is Associated with Primary Graft Dysfunction Following Heart Transplantation: A Report from the International Consortium on Primary Graft Dysfunction. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
15
|
Smith ME, Hardman JC, Mehta N, Jones GH, Mandavia R, Anderson C, Khan M, Abdelaziz A, Al-Dulaimy B, Amin N, Anmolsingh R, Anwar B, Bance M, Belfield K, Bhutta M, Buchanan R, Chandrasekharan D, Chu M, Chundu S, Conroy K, Crundwell G, Daniel M, Daniels J, De S, Dobbs S, Doshi J, Farr M, Ferdous T, Fragkouli E, Freeman S, Ghosh S, Gosnell E, Hannan SA, Heward E, Javed F, John D, Nicholls H, Kasbekar AV, Khan H, Khan H, Khwaja S, Kotecha B, Krishnan M, Kumar N, Lamb T, Lancer H, Manjaly JG, Martinez Del Pero M, McClenaghan F, Milinis K, Mistry N, Mohammed H, Morris E, Morris-Jones S, Padee J, Pal S, Patel S, Pericleous A, Qayyum A, Rouhani M, Saeed H, Santhiyapillai M, Seymour K, Sharma S, Siau R, Singh A, Stapleton E, Stephenson K, Stynes G, Subramanian B, Summerfield N, Swords C, Trinidade A, Tse A, Twumasi E, Ubhi H, Unadkat S, Vijendren A, Wasson J, Watson G, Williams G, Wilson J, Yao A, Youssef A, Lloyd SKW, Tysome JR. Acute otitis externa: Consensus definition, diagnostic criteria and core outcome set development. PLoS One 2021; 16:e0251395. [PMID: 33989313 PMCID: PMC8121300 DOI: 10.1371/journal.pone.0251395] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 04/25/2021] [Indexed: 11/18/2022] Open
Abstract
OBJECTIVE Evidence for the management of acute otitis externa (AOE) is limited, with unclear diagnostic criteria and variably reported outcome measures that may not reflect key stakeholder priorities. We aimed to develop 1) a definition, 2) diagnostic criteria and 3) a core outcome set (COS) for AOE. STUDY DESIGN COS development according to Core Outcome Measures in Effectiveness Trials (COMET) methodology and parallel consensus selection of diagnostic criteria/definition. SETTING Stakeholders from the United Kingdom. SUBJECTS AND METHODS Comprehensive literature review identified candidate items for the COS, definition and diagnostic criteria. Nine individuals with past AOE generated further patient-centred candidate items. Candidate items were rated for importance by patient and professional (ENT doctors, general practitioners, microbiologists, nurses, audiologists) stakeholders in a three-round online Delphi exercise. Consensus items were grouped to form the COS, diagnostic criteria, and definition. RESULTS Candidate COS items from patients (n = 28) and literature (n = 25) were deduplicated and amalgamated to a final candidate list (n = 46). Patients emphasised quality-of-life and the impact on daily activities/work. Via the Delphi process, stakeholders agreed on 31 candidate items. The final COS covered six outcomes: pain; disease severity; impact on quality-of-life and daily activities; patient satisfaction; treatment-related outcome; and microbiology. 14 candidate diagnostic criteria were identified, 8 reaching inclusion consensus. The final definition for AOE was 'diffuse inflammation of the ear canal skin of less than 6 weeks duration'. CONCLUSION The development and adoption of a consensus definition, diagnostic criteria and a COS will help to standardise future research in AOE, facilitating meta-analysis. Consulting former patients throughout development highlighted deficiencies in the outcomes adopted previously, in particular concerning the impact of AOE on daily life.
Collapse
Affiliation(s)
| | - John C Hardman
- The Royal Marsden Hospital London, London, United Kingdom
| | - Nishchay Mehta
- Royal National ENT Hospital London, London, United Kingdom
| | - Gareth H Jones
- Aintree University Hospitals Liverpool, Liverpool, United Kingdom
| | - Rishi Mandavia
- University College London Hospitals NHS Foundation Trust, London, United Kingdom
| | | | - Maha Khan
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | | | | | - Nikul Amin
- Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
| | | | - Bilal Anwar
- Salford Royal Hospital, Salford, United Kingdom
| | - Manohar Bance
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
| | - Katherine Belfield
- School of Medicine, University of Nottingham, Nottingham, United Kingdom
| | - Mahmood Bhutta
- Brighton Sussex University Hospitals, Brighton, United Kingdom
| | | | | | - Michael Chu
- Health Education North West, Manchester, United Kingdom
| | | | - Katherine Conroy
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | - Gemma Crundwell
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
| | - Mat Daniel
- Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| | - Jessica Daniels
- Tameside and Glossop NHS Integrated Care Trust, Ashton-under-Lyne, United Kingdom
| | - Sujata De
- Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom
| | - Sian Dobbs
- Health Education North West, Manchester, United Kingdom
| | - Jayesh Doshi
- Heartlands Hospital Birmingham, Birmingham, United Kingdom
| | - Matthew Farr
- University of Sheffield, Sheffield, United Kingdom
| | - Tanjinah Ferdous
- University College London Hospitals NHS Foundation Trust, London, United Kingdom
| | - Eleni Fragkouli
- Oxford University Hospitals Foundation Trust, Oxford, United Kingdom
| | | | - Samit Ghosh
- Pennine Acute Trust, Manchester, United Kingdom
| | - Emma Gosnell
- Royal Bolton Hospital, Farnworth, United Kingdom
| | - S Alam Hannan
- Royal National ENT Hospital London, London, United Kingdom
| | - Elliot Heward
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | - Faisal Javed
- Heartlands Hospital Birmingham, Birmingham, United Kingdom
| | - Deepa John
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
| | | | - Anand V Kasbekar
- Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| | - Haroon Khan
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | - Hammad Khan
- Royal Preston Hospital, Fulwood, United Kingdom
| | - Sadie Khwaja
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | - Bhik Kotecha
- Nuffield Health Brentwood Hospital, Brentwood, United Kingdom
| | | | - Nirmal Kumar
- Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom
| | - Tamara Lamb
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
| | - Hannah Lancer
- Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
| | | | | | | | - Kristijonas Milinis
- Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom
| | - Nina Mistry
- Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom
| | - Hassan Mohammed
- Newcastle Upon Tyne University Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
| | - Elizabeth Morris
- Nuffield Department of Primary Care Health Sciences, United Kingdom
| | - Stephen Morris-Jones
- University College London Hospitals NHS Foundation Trust, London, United Kingdom
| | - Jessica Padee
- University of Manchester, Manchester, United Kingdom
| | - Surojit Pal
- London North West University Healthcare NHS Trust, London, United Kingdom
| | - Sanjay Patel
- Aintree University Hospitals Liverpool, Liverpool, United Kingdom
| | | | - Asad Qayyum
- North West Anglia NHS Foundation Trust, Peterborough, United Kingdom
| | - Maral Rouhani
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Haroon Saeed
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | | | - Kay Seymour
- Barts Health NHS Trust, London, United Kingdom
| | - Sunil Sharma
- Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom
| | - Richard Siau
- Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
| | - Arvind Singh
- London North West University Healthcare NHS Trust, London, United Kingdom
| | - Emma Stapleton
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | | | - Gill Stynes
- Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
| | | | - Neil Summerfield
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | | | - Aaron Trinidade
- Southend University Hospital NHS Foundation Trust, Southend-on-Sea, United Kingdom
| | - Antonia Tse
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | - Emmanuel Twumasi
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
| | - Harmony Ubhi
- London North West University Healthcare NHS Trust, London, United Kingdom
| | - Samit Unadkat
- Royal National ENT Hospital London, London, United Kingdom
| | | | - Joe Wasson
- East Kent Hospitals NHS Foundation Trust, Canterbury, United Kingdom
| | - Glen Watson
- Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
| | | | - Janet Wilson
- Newcastle Upon Tyne University Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
| | | | - Ahmed Youssef
- Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
| | - Simon K W Lloyd
- Manchester University NHS Foundation Trust, Manchester, United Kingdom
| | | | | |
Collapse
|
16
|
Diakos N, Latif F, Takeda K, Clerkin K, Habal M, Naka Y, Restaino S, Oh K, Sayer G, Farr M, Uriel N. Six-Month Outcomes of Heart Transplant Recipients Infected by COVID-19. J Heart Lung Transplant 2021. [PMCID: PMC7979377 DOI: 10.1016/j.healun.2021.01.373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
17
|
Yopes M, Clerkin K, Fried J, Griffin J, Raikhelkar J, Topkara V, Kim A, Habal M, Latif F, Restaino S, Yuzefpolskaya M, Farr M, Colombo P, Sayer G, Uriel N. Continuous Intermittent Intravenous Immunoglobulin in Heart Transplant Recipients with Elevated Donor-Specific Antibody Levels. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
18
|
Slomovich S, Raikhelkar J, Fried J, Griffin J, Clerkin K, Roth Z, Kim A, Farr M, Topkara V, Latif F, Axsom K, Yuzefpolskaya M, Colombo P, Takeda K, Naka Y, Uriel N, Sayer G. The Utility of Televisits in Patients with a Left Ventricular Assist Device. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
19
|
Golob S, Batra J, Godfrey S, Slomovich S, Fried J, Clerkin K, Griffin J, Takeda K, Naka Y, Topkara V, Habal M, Latif F, Restaino S, Farr M, Yuzefpolskaya M, Colombo P, Sayer G, Uriel N, Raikhelkar J. Clinical Characteristics and Outcomes of Cancer Survivors Undergoing Heart Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
20
|
Bell J, Yuzefpolskaya M, Latif F, Restaino S, Uriel N, Sayer G, Dadhania D, Farr M, Sharma V, Habal M. Allosensitization in Heart Transplantation: The Importance of a Comprehensive Approach. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.2014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
21
|
Slomovich S, Roth Z, Clerkin K, Kleet A, Walraven O, Kim A, Colombo P, Raikhelkar J, Griffin J, Farr M, Yuzefpolskaya M, Fried J, Latif F, Restaino S, Topkara V, Uriel N, Sayer G. Remote Monitoring of Heart Transplant Recipients during the COVID-19 Pandemic. J Heart Lung Transplant 2021. [PMCID: PMC7979368 DOI: 10.1016/j.healun.2021.01.1800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Purpose The COVID-19 pandemic created significant challenges in monitoring heart transplant (HT) recipients for rejection due to efforts to minimize contact with the hospital setting. The aim of this study was to evaluate the safety and efficacy of transitioning HT patients to home phlebotomy and a monitoring protocol based on gene expression profiling (GEP) and donor derived cell free DNA (ddcfDNA). Methods A single-center cohort study that prospectively enrolled consecutive HT patients who were transitioned to a remote monitoring protocol employing home phlebotomy and non-invasive surveillance for rejection. Patients were enrolled starting at 2 months post-HT. Positive GEP values were defined as ≥32 (up to 6 months post-HT) and ≥34 (> 6 months post-HT). A positive ddcfDNA score was defined as >0.12%. A positive biopsy was defined as grade ≥1B/1R Results 246 HT patients were enrolled and followed for a minimum of 3 months. Mean age was 56±14, 71.5% were male, and median time from transplant was 2.7 years. The average distance of patients from the hospital was 25.6 miles. 359 blood tests were drawn for detection of GEP and ddcfDNA and 102 biopsies performed (Figure). Among 32 patients who had negative results on both tests and had a biopsy, 0 had a positive biopsy. Of 25 patients who had positive results on both tests and had a biopsy, 3 (12%) had a positive biopsy. The biopsy positivity rate in patients who were GEP+/ddcfDNA- was 6% and in patients who were GEP-/ddcfDNA+ was 8%. None of the positive biopsies were associated with hemodynamic compromise. 15 (6%) of patients were admitted due to allograft rejection during the study period. There were no deaths. Conclusion Using a remote monitoring protocol with home phlebotomy and noninvasive rejection surveillance was feasible and safe in HT recipients. In this cohort, the combination of negative GEP and ddcfDNA scores was accurate at predicting a lack of allograft rejection.
Collapse
|
22
|
Hood S, Barrickman N, Djerdjian N, Farr M, Magner S, Roychowdhury H, Gerrits R, Lawford H, Ott B, Ross K, Paige O, Stowe S, Jensen M, Hull K. "I Like and Prefer to Work Alone": Social Anxiety, Academic Self-Efficacy, and Students' Perceptions of Active Learning. CBE Life Sci Educ 2021; 20:ar12. [PMID: 33600218 PMCID: PMC8108489 DOI: 10.1187/cbe.19-12-0271] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Although active learning improves student outcomes in science, technology, engineering, and mathematics (STEM) programs, it may provoke anxiety in some students. We examined whether two psychological variables, social anxiety (psychological distress relating to the fear of negative evaluation by others) and academic self-efficacy (confidence in one's ability to overcome academic challenges), interact with student perceptions of evidence-based instructional practices (EBIPs) and associate with their final grades in a STEM-related course. Human anatomy and physiology students in community college courses rated various EBIPs for their perceived educational value and their capacity to elicit anxiety (N = 227). In general, practices causing students the most anxiety (e.g., cold calling) were reported by students as having the least educational value. When controlling for students' self-reported grade point averages, socially anxious students rated several EBIPs as more anxiety inducing, whereas high-efficacy students reported less anxiety surrounding other EBIPs. Furthermore, mediation analysis revealed that individual differences in academic self-efficacy at the beginning of the term explained some of the negative association between students' social anxiety levels and final grades in the course. Our results, obtained in a community college context, support a growing body of evidence that social anxiety and academic self-efficacy are linked with how students perceive and perform in an active-learning environment.
Collapse
Affiliation(s)
- S. Hood
- Bishop’s University, Sherbrooke, QC J1M 1Z7, Canada
- *Address correspondence to: Suzanne Hood (); N. Barrickman ()
| | - N. Barrickman
- Department of Biology, Salt Lake City Community College, Salt Lake City, UT 84123
- *Address correspondence to: Suzanne Hood (); N. Barrickman ()
| | - N. Djerdjian
- Department of Biology, Anoka-Ramsey Community College, South Cambridge, MN 55008-5704
| | - M. Farr
- Department of Biology, Salt Lake City Community College, Salt Lake City, UT 84123
| | - S. Magner
- Department of Biology, Anoka-Ramsey Community College, South Cambridge, MN 55008-5704
| | - H. Roychowdhury
- Science Department, Doña Ana Community College, Las Cruces, NM 88011
| | - R. Gerrits
- Department of Electrical Engineering and Computer Science, Milwaukee School of Engineering, Milwaukee, WI 53202-3109
| | - H. Lawford
- Bishop’s University, Sherbrooke, QC J1M 1Z7, Canada
| | - B. Ott
- Department of Biology, Tyler Junior College, Tyler, TX 75711-9020
| | - K. Ross
- Department of Biomedical Engineering, Georgia Tech and Emory University, Atlanta, GA 30332; and
| | - O. Paige
- Bishop’s University, Sherbrooke, QC J1M 1Z7, Canada
| | - S. Stowe
- Bishop’s University, Sherbrooke, QC J1M 1Z7, Canada
| | - M. Jensen
- **College of Biological Sciences, University of Minnesota, Minneapolis, MN 55455
| | - K. Hull
- Bishop’s University, Sherbrooke, QC J1M 1Z7, Canada
| |
Collapse
|
23
|
Jain R, Habal M, Restaino S, Latif F, Truby L, Clerkin K, Raikhelkar J, Fried J, Masoumi A, Yuzefpolskaya M, Colombo P, Sayer G, Takayama H, Takeda K, Naka Y, Farr M, Uriel N, Topkara V. De-Novo Human Leukocyte Antigen Allosensitization on HeartMate 3 versus HeartMate II Left Ventricular Assist Device Recipients. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
24
|
Pinsino A, Jennings D, Mahoney I, Sweat A, Kim A, Mondellini G, Farhana L, Restaino S, Habal M, Farr M, Faillace R, Takeda K, Naka Y, Demmer R, Radhakrishnan J, Colombo P, Yuzefpolskaya M. Serum Cystatin C versus Creatinine Based Assessment of Renal Function in Heart Transplant Patients. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
25
|
Truby L, Farr M, Defillipis E, Takeda K, Takayama H, Colombo P, Yuzefpolskaya M, Haythe J, Axsom K, Naka Y, Uriel N, Topkara V. Utilization of Mechanical Circulatory Support Devices and Impact on Outcomes in the New Heart Allocation System: An Analysis of the UNOS Registry. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
26
|
Jennings D, Salerno D, Lange N, Clerkin K, Axsom K, Lin E, Restaino S, Latif F, Topkara V, Yuzefpolskaya M, Takeda K, Colombo P, Farr M. Faster Time-to-Therapeutic Tacrolimus Level is Associated with Lower Risk of Cellular Rejection Early after Heart Transplantation. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
27
|
Marshall D, DeFilippis E, Truby L, Malick A, Butler C, Griffin J, Clerkin K, Fried J, Raikhelkar J, Yuzefpolskaya M, Colombo P, Sayer G, Takeda K, Takayama H, Naka Y, Farr M, Uriel N, Topkara V. Increased Right Ventricular Assist Device (RVAD) Utilization in Patients with HeartMate 3 Left Ventricular Assist Device (LVAD) in the Post-Approval Era. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
28
|
Jennings D, Truby L, Fried J, Clerkin K, Griffin J, Raikhelkar J, Axsom K, Lin E, Haythe J, Yuzefpolskaya M, Colombo P, Sayer G, Farr M, Takayama H, Takeda K, Naka Y, Uriel N, Topkara V. Impact of Heart Failure Drug Therapy on GI Bleeding Rates in LVAD Recipients: An INTERMACS Analysis. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
29
|
Jennings D, Pinsino A, Mahoney I, Sweat A, Mondellini G, Braghieri L, Hupf J, Gaine M, Latif F, Restaino S, Clerkin K, Topkara V, Farr M, Takeda K, Naka Y, Sayer G, Uriel N, Colombo P, Yuzefpolskaya M. Use of Serum Cystatin C versus Creatinine for Estimation of Renal Function and Valganciclovir Dosing in Heart Transplant Recipients. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
30
|
Batra J, Truby L, Garan R, Haythe J, Lin E, Axsom K, Yuzefpolskaya M, Colombo P, Sayer G, Takayama H, Takeda K, Naka Y, Farr M, Uriel N, Topkara V. C-reactive Protein Levels Predict Right Ventricular Failure and Mortality in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Assist Device Implantation: An INTERMACS Analysis. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
31
|
Batra J, Marshall D, Jennings D, Truby L, DeFilippis E, Malick A, Butler C, Griffin J, Masoumi A, Clerkin K, Raikhelkar J, Fried J, Yuzefpolskaya M, Colombo P, Sayer G, Takayama H, Takeda K, Naka Y, Farr M, Topkara V, Uriel N. Elevated Serum C-reactive Protein (CRP) Level Predicts Increased Post-Implant Mortality in Patients Undergoing HeartMate 3 LVAD Implantation. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
32
|
Vermaak PV, D’Asta F, Provins J, Farr M, Wilson YT. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom. Burns 2019; 45:1379-1385. [DOI: 10.1016/j.burns.2019.04.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 03/09/2019] [Accepted: 04/02/2019] [Indexed: 12/01/2022]
|
33
|
Grubb C, Bohnen M, Kleet A, Topkara V, Garan A, Bijou R, Maurer M, Garan H, Farr M. Home Inotropic Therapy as a Bridge and as Destination: Intended and Unintended Outcomes in a Single Center Contemporary Cohort. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
34
|
Sanchez J, Farr M, Restaino S, Jennings D, Topkara V, Garan A, Kurlansky P, Colombo P, Takayama H, Naka Y, Takeda K. Peri-Operative Serum Amiodarone Levels are Not Predictive of Graft Dysfunction in Orthotopic Heart Transplantation. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
35
|
Stanford N, McAllister J, Addonizio L, Richmond M, Law S, Lee T, Farr M, Gibbons M, Jensen K, Lee H, Rothkopf A, Jackson R, Zuckerman W. Lifetime Achievement and Quality of Life in Adult Survivors of Pediatric Heart Transplant. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
36
|
Jackson R, Jennings D, Gaine M, Fanek T, Mabasa A, Lee J, Kleet A, Latif F, Restaino S, Farr M. Use of PCSK9 Inhibitor Therapy in a Small Cohort of Heart Transplant Recipients with Statin Intolerance or Refractory Hyperlipidemia. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
37
|
Habal M, Myung A, Rao S, See S, Shihab R, Roy P, Marboe C, Restaino S, Han A, Givertz M, Madsen J, Addonizio L, Farr M, Zorn E. Clonal Composition and Single-Cell Characterization of T-Cell Infiltrates in Cardiac Allograft Vasculopathy. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
38
|
Batra J, Jennings D, Garan A, Truby L, Latif F, Restaino S, Haythe J, Yuzefpolskaya M, Takeda K, Takayama H, Naka Y, Colombo P, Farr M, Topkara V. Outcomes after Early Initiation of mTOR-Inhibitors in Adult Cardiac Transplant Recipients. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
39
|
Truby L, Farr M, Topkara V. One but Not the Same: Risk Factors for Early Post-Transplant Mortality Differ between Medically Managed Patients and Those Bridged to Transplant with Left Ventricular Assist Devices. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
40
|
Giangreco N, Lebreton G, Restaino S, Farr M, Colombo P, Zorn E, Tatonetti N, Leprince P, Kobashigawa J, Fine B. Exosome Proteomics and Machine Learning Identify Novel Biomarkers of Primary Graft Dysfunction. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.325] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
41
|
Breslin N, Salerno D, Restaino S, Latif F, Takeda K, Takayama H, Farr M, Colombo P, Jennings D. Pre-transplant Amiodarone Reduces Weight-based Tacrolimus Dosing Requirements in Heart Transplant Recipients. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
42
|
Han J, Ando M, Garan A, Farr M, Colombo P, Takayama H, Naka Y, Takeda K. Post-Transplant Outcomes of Patients Initially Receiving Left Ventricular Assist Device as Either Bridge to Candidacy or Destination Therapy. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
43
|
Coromilas E, Garan A, Yuzefpolskaya M, Takeda K, Takayama H, Farr M, Naka Y, Colombo P, Topkara V. Cardiac Recovery in Patients with Adriamycin-Induced Cardiomyopathy After Left Ventricular Assist Device Support. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.674] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
44
|
Lange N, Baker W, Shullo M, Latif F, Restaino S, Takeda K, Takayama H, Naka Y, Farr M, Colombo P, Jennings D. Outcomes Associated With Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-analysis. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
45
|
Rubin G, Sanchez J, Bayne J, Takayama H, Takeda K, Naka Y, Garan H, Farr M, Wan. E. Clinical Outcomes After Tricuspid Annuloplasty Prior to Cardiac Transplantation: A Single Center Experience. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
46
|
Farr M, Lindower J, Taylor S, Jorde U, Chen L, Gass A, Truby L, DeLair S, Pinney S. Increase in DCD Donation in the United States May Adversely Impact DBD Heart Transplantation: Retrospective Analysis of a Limited UNOS Dataset. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
47
|
Fine B, Chen E, Lebreton G, Restaino S, Taupin J, Zorn E, Farr M, Colombo P, Leprince P. Pre-Transplant Serum Exosome Proteomics Differentiates Right and Left Ventricular Primary Graft Dysfunction. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
48
|
Ando M, Takayama H, Kurlansky P, Han J, Garan A, Topkara V, Yuzefpolskaya M, Colombo P, Farr M, Naka Y, Takeda K. Pre-Transplant Estimated Glomerular Filtration Rate Less Than 40 Provides Similar Risks of Post-transplant Mortality Both in LVAD and Non-LVAD Heart Transplant Recipients. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
49
|
Hoemann B, Takayama H, Wright M, Jennings D, Han J, Restaino S, Colombo P, Farr M, Naka Y, Takeda K. Discontinuing Amiodarone Treatment Prior to Heart Transplant May Lower Incidence of Severe Primary Graft Dysfunction. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
50
|
Truby L, Garan A, Givens R, Takayama H, Yuzefpolskaya M, Takeda K, Latif F, Restaino S, Naka Y, Colombo P, Farr M, Uriel N, Topkara V. Pulmonary Artery Decoupling Further Enhances Discriminatory Power of Pulmonary Vascular Resistance in Patients Bridged to Transplant with Left Ventricular Assist Devices. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|